Barbara M. Fischer

St Thomas' Hospital Westminster Bridge Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of Thoracic Oncology Volume 20 Issue 8 (2025) 1086-1097].

Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of Thoracic Oncology Volume 20 Issue 8 (2025) 1086-1097].

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 24, 2026

Pilot Study on Dynamic Long-Axial Field-of-View [18F]FDG PET/CT in Liver Transplant Recipients as a Non-Invasive Alternative to Routine Biopsies.

Pilot Study on Dynamic Long-Axial Field-of-View [18F]FDG PET/CT in Liver Transplant Recipients as a Non-Invasive Alternative to Routine Biopsies.

Journal: Diagnostics (Basel, Switzerland)

Published: February 21, 2026

Diagnostic Accuracy of [18F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical Trial.

Diagnostic Accuracy of [18F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical Trial.

Journal: Clinical lung cancer

Published: September 29, 2025

Normal twin PET: personalized generative modeling for confounder correction and anomaly detection in whole-body PET/CT.

Normal twin PET: personalized generative modeling for confounder correction and anomaly detection in whole-body PET/CT.

Journal: Scientific reports

Published: August 28, 2025

Non-inferiority of automated deep learning-based [18F]FDG PET/CT tumour volume compared to manual GTV for prognostic modelling in head and neck cancer.

Non-inferiority of automated deep learning-based [18F]FDG PET/CT tumour volume compared to manual GTV for prognostic modelling in head and neck cancer.

Journal: EJNMMI research

Published: July 10, 2025

External validation of deep learning-derived 18F-FDG PET/CT delta biomarkers for loco-regional control in head and neck cancer.

External validation of deep learning-derived 18F-FDG PET/CT delta biomarkers for loco-regional control in head and neck cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 30, 2025

Malignancy Detection Rates of [68Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung Cancer.

Malignancy Detection Rates of [68Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 19, 2025

Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers.

Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 26, 2025

ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach.

ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 21, 2025

Correction: Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer.

Correction: Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 03, 2025

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial.

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 18, 2024

Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC.

Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC.

Journal: Diagnostics (Basel, Switzerland)

Published: November 26, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026